Efficacy of capecitabine vs. infusional 5-FU as neoadjuvant chemoradiotherapy for rectal cancer

被引：0
|
作者：
Kocakova, I [1 ]
Kubala, E. [2 ]
Spurny, V
Dvorak, J.
Finek, J. [3 ]
Cwiertka, K. [4 ]
Prausova, J. [2 ]
Hoch, J. [2 ]
Vyzula, R. [1 ]
机构：
[1] Masaryk Oncol Inst, Brno, Czech Republic
[2] Fac Hosp Motol, Prague, Czech Republic
[3] Fac Hosp Plzen, Plzen, Czech Republic
[4] Fac Hosp Olomouc, Olomouc, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [31] A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer
    Zhao, Lin
    Bai, Chunmei
    Shao, Yajuan
    Guan, Mei
    Jia, Ning
    Xiao, Yi
    Qiu, Huizhong
    Zhang, Fuquan
    Yang, Ti
    Zhong, Guangxi
    Chen, Shuchang
    [J]. CANCER LETTERS, 2011, 310 (02) : 134 - 139
  • [32] Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer
    Joybari, Ali Yaghobi
    Azadeh, Payam
    Babaei, Siamak
    Kamal, Farnaz Hosseini
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (04) : 1599 - 1605
  • [33] QUANTITATIVE ASPECTS OF COMBINED INFUSIONAL 5-FU AND RADIATION IN ADVANCED CANCER
    BYFIELD, JE
    [J]. BRITISH JOURNAL OF CANCER, 1981, 44 (02) : 288 - 289
  • [34] Efficacy and safety findings from a randomized phase III study of capecitabine (X) plus oxaliplatin (O) (XELOX) vs. infusional 5-FU/LV + O (FOLFOX-6) for metastatic colorectal cancer (MCRC)
    Ducreux, M.
    Bennouna, J.
    Hebbar, M.
    Ychou, M.
    Lledo, G.
    Conroy, T.
    Adenis, A.
    Faroux, R.
    Rebischung, C.
    Douillard, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.
    Yu, Irene
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses
    Schmoll, H. J.
    Stein, A.
    Hofheinz, R. D.
    Price, T. J.
    Nordlinger, B.
    Daisne, J-F.
    Daisne, J-F.
    Janssens, J.
    Brenner, B.
    Schmidt, P.
    Reinel, H.
    Hollerbach, S.
    Caca, K.
    Fauth, F.
    Zalcberg, J.
    Marreaud, S.
    Mauer, M.
    Lutz, M.
    Van Cutsem, E.
    Haustermans, K.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [37] Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses
    Stein, A.
    Schmoll, H. -J
    Hofheinz, R. D.
    Price, T.
    Nordlinger, B.
    Daisne, J-F
    Janssens, J.
    Brenner, B.
    Schmidt, P.
    Reinel, H.
    Hollerbach, S.
    Caca, K.
    Fauth, F. W. B.
    Hannig, C.
    Zalcberg, J. R.
    Marreaud, S.
    Tebbutt, N. C.
    Mauer, M. E.
    Lutz, M. P.
    Van Cutsem, E.
    Haustermans, K.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 197 - 197
  • [38] Effects of 5-FU dose monitoring under neoadjuvant radiochemotherapy for locally advanced rectal cancer
    Quack, H.
    Stanek, K.
    Wolff, H.
    Droege, L. H.
    Binder, L.
    Bleckmann, A.
    Nietert, M.
    Beissbarth, T.
    Lorenzen, S.
    Liersch, T.
    Ghadimi, M.
    Conradi, L-C
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 83 - 83
  • [39] Efficacy of adjuvant chemotherapy with 5-FU/leucovorin and 5-FU/levamisole colon cancer
    Porschen, R
    Bermann, A
    Löffler, T
    Haack, G
    Rettig, K
    Anger, Y
    Strohmeyer, G
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A664 - A664
  • [40] Neoadjuvant Chemoradiation of Rectal Cancer with UFT and Leucovorin Compared with 5-FU und Leucovorin Comment
    Klautke, Gunther
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (01) : 53 - 54
12345